HCC
Hirtle Callaghan & Co’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,447
| Closed | -$275K | – | 113 |
|
|
2022
Q2 | $275K | Hold |
4,447
| – | – | 0.02% | 108 |
|
|
2022
Q1 | $264K | Buy |
+4,447
| New | +$264K | 0.01% | 118 |
|
|
2017
Q4 | – | Sell |
-404
| Closed | -$33K | – | 182 |
|
|
2017
Q3 | $33K | Hold |
404
| – | – | ﹤0.01% | 121 |
|
|
2017
Q2 | $28K | Sell |
404
-100
| -20% | -$6.93K | ﹤0.01% | 104 |
|
|
2017
Q1 | $34K | Sell |
504
-1,700
| -77% | -$115K | 0.01% | 108 |
|
|
2016
Q4 | $158K | Sell |
2,204
-1,148
| -34% | -$82.3K | 0.03% | 29 |
|
|
2016
Q3 | $265K | Buy |
3,352
+850
| +34% | +$67.2K | 0.05% | 76 |
|
|
2016
Q2 | $209K | Sell |
2,502
-1,566
| -38% | -$131K | 0.04% | 79 |
|
|
2016
Q1 | $374K | Hold |
4,068
| – | – | 0.07% | 60 |
|
|
2015
Q4 | $411K | Sell |
4,068
-73
| -2% | -$7.38K | 0.1% | 17 |
|
|
2015
Q3 | $408K | Hold |
4,141
| – | – | 0.07% | 29 |
|
|
2015
Q2 | $485K | Buy |
+4,141
| New | +$485K | 0.16% | 22 |
|
|
2015
Q1 | – | Sell |
-6,456
| Closed | -$609K | – | 160 |
|
|
2014
Q4 | $609K | Buy |
6,456
+2,594
| +67% | +$245K | 0.14% | 94 |
|
|
2014
Q3 | $411K | Sell |
3,862
-138
| -3% | -$14.7K | 0.07% | 123 |
|
|
2014
Q2 | $332K | Buy |
4,000
+800
| +25% | +$66.4K | 0.05% | 188 |
|
|
2014
Q1 | $227K | Buy |
3,200
+2,300
| +256% | +$163K | 0.04% | 224 |
|
|
2013
Q4 | $68K | Buy |
+900
| New | +$68K | 0.01% | 300 |
|